在高风险儿科创伤患者中进行静脉血栓塞栓预防
Amanda B Witte1, Kyle Van Arendonk2, Carisa Bergner1
1Children's Wisconsin, Medical College of Wisconsin, Milwaukee.
JAMA surgery
|July 31, 2024
概括
化学静脉血栓塞栓症预防 (cVTE) 在高危儿科创伤患者中是安全的. 延迟cVTE启动会增加VTE的风险,这凸显了儿童创伤护理中及时预防的重要性.
科学领域:
- 儿科创伤护理 儿童创伤护理
- 静脉血栓栓塞的预防 预防 静脉血栓塞的预防
- 药理学 药理学是指药理学的学科.
背景情况:
- 在儿童创伤患者中,化学静脉血栓塞栓症预防 (cVTE) 的安全性和有效性尚未得到充分证实.
- 最近的建议提出了使用cVTE的高风险标准,但缺乏前性评估.
研究的目的:
- 预期评估高风险标准和儿童创伤患者中cVTE的使用.
- 评估cVTE在预防静脉血栓塞栓症 (VTE) 的安全性和有效性.
主要方法:
- 一项前性,多机构的队列研究,涉及8个I级儿科创伤中心.
- 包括儿童创伤患者 (<18岁) 满足定义的高风险标准.
- 评估接收,cVTE的时间,VTE率和安全结果 (出血并发症).
主要成果:
- 研究了460名高危儿科创伤患者,54.5%接受了cVTE.
- 在接受24小时内cVTE的患者中,VTE发生在1.6%,24小时后接受cVTE的患者为6.9%,没有接受cVTE的患者为5.3%.
- 延迟cVTE启动 (24小时后) 与增加VTE风险 (或1.01) 有显著的关联.
- 在使用cVTE时没有观察到出血并发症.
结论:
- 在高危儿科创伤患者中,cVTE是安全的,没有观察到出血并发症.
- 及时启动cVTE (24小时内) 对于有效预防VTE至关重要.
- 质量改进工作应集中于优化预防时间和解决实施障碍.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
659
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
659
Disorders of Hemostasis
781
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
781


